1st Circ. Crushes Objection To $24M Zoladex Deal

By Jesse Greenspan

Law360, New York (November 20, 2009, 6:41 PM ET) -- A federal appeals court panel has upheld a $24 million settlement in a class action that accused AstraZeneca Pharmaceuticals LP of artificially inflating prices for the prostate cancer drug Zoladex.

One unhappy named plaintiff, M. Joyce Howe, had challenged the settlement in the U.S. Court of Appeals for the First Circuit, saying all recovery should be distributed to class members rather than having some go into a cy pres fund for charity.

She also argued that the settlement was improperly negotiated, that its method for calculating...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles